Ignite Creation Date:
2024-05-06 @ 3:17 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04585997
Status:
UNKNOWN
Last Update Posted:
2020-10-14
First Post:
2020-09-30
Brief Title:
Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - Choosebetweenamab
Sponsor:
University of Newcastle Australia
Organization:
University of Newcastle Australia
Organization Data
Organization:
University of Newcastle Australia
Class:
OTHER
Study ID:
180815301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Newcastle Australia
Lead Sponsor Class:
OTHER
Responsible Party:
Professor Peter Wark
Responsible Party Title:
Professor and Senior Staff Respiratory Specialist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Newcastle Australia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |